Diagnostic Approach to Pancytopenia with Macrocytosis
Initial Assessment and Differential Diagnosis
- The American Society of Clinical Oncology recommends that patients with pancytopenia and macrocytosis undergo a bone marrow aspiration and biopsy with cytogenetic analysis to determine the underlying cause, which is likely a bone marrow disorder such as myelodysplastic syndrome or vitamin B12 deficiency 1
- A combination of pancytopenia with macrocytosis is concerning for a primary bone marrow disorder, nutritional deficiency, or medication effect, with a homogeneous red cell population suggested by normal MCHC and RDW values 1, 2
- Myelodysplastic syndrome should be strongly considered given the combination of pancytopenia with macrocytosis, according to the American Society of Hematology 1
- Aplastic anemia can present with pancytopenia but typically without macrocytosis, as noted by the American College of Physicians 3
Diagnostic Workup and Management
- The National Comprehensive Cancer Network recommends bone marrow aspiration and biopsy with cytogenetic analysis as the most critical next step to evaluate for myelodysplastic syndrome, leukemia, or other bone marrow disorders 1
- Vitamin B12 and folate levels are essential to rule out nutritional causes of macrocytic pancytopenia, with the Endocrine Society recommending parenteral B12 supplementation for deficiency 4
- Iron studies, including serum ferritin, iron, TIBC, and transferrin saturation, can help evaluate for iron deficiency that may be masked by macrocytosis, as suggested by the American Society of Clinical Oncology 4
- A medication review is necessary to evaluate all current medications for potential myelosuppressive effects, with the American College of Clinical Pharmacy recommending consideration of discontinuation or dose reduction of the offending medication 2
Follow-up and Monitoring
- Close monitoring of CBC is essential regardless of the underlying cause, with the American Society of Clinical Oncology recommending follow-up guided by a hematologist for patients with confirmed bone marrow disorders 3, 2
- For patients with nutritional deficiencies, repeat CBC after 4-8 weeks of supplementation to assess response, as recommended by the National Institutes of Health 4